Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sanhuang Zhenzhu ointment (also known as Sanhuang Zhenzhu Gao) is a topical traditional Chinese medicine (TCM) ointment developed and manufactured by Henan Lingrui Biological Pharmaceutical. It is a multi-component herbal and mineral preparation containing prepared sulphur, prepared realgar, prepared gamboge, pearl, and artificial musk. The ointment is approved in China for the treatment of medium and small area second-degree burns, scalds, and residual sores. It has also been clinically evaluated for the treatment of diabetic foot ulcers, where it has demonstrated safety and efficacy in improving local wound microenvironment factors. Its therapeutic actions include resolving toxins, dispersing swelling, removing necrotic tissue, promoting granulation, and relieving pain.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sanhuang Zhenzhu ointment.